BioprintingCareer MovesWomen of 3D Printing

CELLINK brings on Distinguished Scientist Dr. Mina Bissell to advisory board

Dr. Bissell will contribute with unique experience in cancer research

Dr. Mina Bissell has joined the Advisory Board at 3D bioprinter manufacturer CELLINK and will contribute to the company’s development within cancer research and focus on developing technologies advancing the field. The Iranian born scientist runs the Bissell Lab at Lawrence Berkeley National Laboratory and has been recognized for her lifetime contributions to the fields of breast cancer research, the enhanced role of extracellular matrix (ECM) and the nucleus environment to gene expression in normal and malignant tissues. These works have ushered and have changed some central paradigms that have strengthened the importance of context in the development of cancer.

In addition, she was named Distinguished Scientist, the highest rank bestowed at Lawrence Berkeley National Laboratory (LBNL), and serves as Senior Advisor to the Laboratory Director on Biology. She is also Faculty of four Graduate Groups in UC Berkeley: Comparative Biochemistry, Endocrinology, Molecular Toxicology, and Bioengineering (UCSF/UCB joint program).

Dr. Mina Bissell joins CELLINK

Having challenged several established paradigms, Bissell is a pioneer in breast cancer research and her body of work has provided much impetus for the current recognition of the significant role that extracellular matrix (ECM) signaling and microenvironment play in gene expression regulation in both normal and malignant cells. Her laboratory developed novel 3D assays and techniques that demonstrate her signature phrase: after conception, “phenotype is dominant over genotype.”

As the company continues to enjoy rapid growth, the CELLINK advisory board now consist of 4 advisors who have covered and continue to cover highly relevant positions in the medical industry and academia. Rolf Claesson served as Chairman of Bayer HealthCare and Tecan Group, as well as CEO of Bayer Diagnostics. Dr. Ali Khademhosseini, served as Professor at Harvard-MIT, Brigham and Women’s Hospital and Harvard Medical School. Dr. David Williams is a Professor at Wake Forest School of Medicine and is regarded as a leading authority on biomaterials, medical devices, and biocompatibility. He authored and co-authored over 400 technical papers within his field of expertise.

Tags
Research 2020
Composites AM Market Opportunities

This 170-page study from 3dpbm Research provides an in-depth analysis of each major sub-segment in composites...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst for leading US-firm SmarTech Analysis, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he Co-founded London-based 3dpbm. Today the company publishes the leading news and insights websites 3D Printing Media Network and Replicatore, as well as 3D Printing Business Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services
Close
Close

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!